NanoLogix Study Confirms Early Success Of Hydrogen Bioreactor

Recently, NanoLogix, Inc. signed a feasibility study with the Department of Environmental Science and Engineering of Gannon University in Erie, PA to develop a bioreactor which utilizes patented bacterial culturing methods in order to produce hydrogen inexpensively. Hydrogen reacts with oxygen to yield significant amounts of energy, and has the added benefit of not producing carbon dioxide as a by-product.



NanoLogix believes they have discovered the most likely method for low cost production of massive quantities of hydrogen as an alternate energy source. The company has ascertained through its patent counsel that additional patents will be pending beyond those already filed.



NanoLogix, Inc., formerly known as Infectech, Inc., is a technology application innovator of biogas products and services designed to assist in worldwide energy independence and reduce pollution from renewable, environmentally-friendly energy sources.

Source: NanoLogix, Inc.

Source: on pressbot.org | Date: 20.08.2005 - 1:48 | 538 times read